About us

Established in 1972, Scrip World Pharmaceutical News is the leading source of global news in the pharmaceutical industry. Delivering an unrivalled range of pharma market intelligence, Scrip's network of experienced, locally based journalists provide you with a truly international and independent perspective.

Scrip World Pharmaceutical News keeps readers abreast of licensing activity, distribution and trade agreements, the actions of companies and associations, and of the policies and practices of governments and their agencies.

From drug manufacturers to CROs, biotech companies to regulators, Scrip subscribers know the value of the unbiased, independent pharmaceutical business intelligence that only Scrip provides.

Sign-up for our FREE 5 day trial to get your FREE daily e-mails covering all the latest pharma & biotech research news including:

A subscription to Scrip includes:

Daily email headlines, now with stories grouped by region and market

Policy & Regulation News – keeping you fully briefed on activities of the national agencies around the world including the US FDA and Europe’s EMEA, and providing you with the latest political moves affecting your industry.

Business News – from start-ups to multinationals, we cover it all.
- Mergers, acquisitions & joint ventures 
- Investments & restructuring
- Financial results & rankings
- Patent & other legal disputes
- Marketing strategies 
- Licensing activity

Research & Development News – covering all significant developments including:
- Launches, withdrawals & approvals
- New formulations & delivery systems
- Therapy profiles
- Clinical trial updates

Access to additional online stories not published in the weekly print and PDF issues

The searchable news archive function of Scrip allows you to search any of Scrip’s stories as far back as 1995.

Scrip World Pharmaceutical News newsletter- weekly issues of Scrip in the new user friendly format, available as print or PDF  

Bespoke Scrip supplements – in-depth coverage of the hottest topics covering sectors such as drug delivery, biotechnology and key pharma conferences

Executive Briefings – every month, senior analysts, leading experts and journalists write an in-depth report which provides you with high-level strategic intelligence on key areas such as:
- Regional markets – North America, Europe, Asia and emerging markets
- Drug markets such as oncology, cardiology, CNS and metabolic diseases 
- Business development activities such as M&A, licensing, regulation and distribution 

Market Insights – every issue contains a critical review of key drug market sectors, companies and clinical developments giving you insight into specific areas such as:
- The latest therapeutics advances in diabetes
- Analysis of market trends and geographic growth
- Regulatory decision-making
- The development of key sectors
- New technologies
- Company profiles
- Analysis of government policy on healthcare

Pipeline Watch – tracking 7,000 drugs in the R&D pipeline: every month you receive up-to-date data on your competitors’ R&D activity in the critical final stage of clinical development.

People - Talented employees are the lifeblood of any organisation. Discover where the high fliers are going, or why they’re leaving. Keep track of the medical opinion leaders who determine the direction of research and clinical practice.